TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
VANI

Vivani Medical Inc.

Healthcare · Biotechnology

1.20$ -3.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VANI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
104.7% 48.1% 234.6% 97.4% 70.9% 63.7% 16,700.0% 132,692.3%
-4.7% 51.9% -134.6% 2.6% 29.1% 36.3% -16,700.0% -132,692.3%
148.4% 33.9% 134.2% 100.4% 148.0% 488.2% 686,500.0% 4,231,538.5%
193.2% 91.9% 252.9% 137.3% 155.0% 273.0% 237,800.0% 892,692.3%
620.2% 275.9% 698.8% 363.1% 534.1% 941.8% 924,300.0% 5,124,230.8%
-624.9% -224.0% -833.4% -360.5% -505.0% -905.5% -924,300.0% -5,124,230.8%
207.0% 0.3% 0.0% 0.0% 0.0% 211,538.5%
-1,036.0% -223.7% -832.6% -358.1% -508.9% -994.1% -927,900.0% -4,912,692.3%
-204.1% 0.6% 0.8% 1.2% 1.2% 10.7% 14,770.3% -246,538.5%
-1,036.0% -223.7% -832.6% -358.1% -508.9% -994.1% -927,900.0% -4,912,692.3%
-820.8% -219.9% -821.8% -352.3% -502.6% -981.9% -888,900.0% -4,780,000.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?